Previous studies have pointed out that miR-29a promotes hepatitis B virus (HBV) replication and expression by targeting SMARCE1 in hepatocellular carcinoma [21], and miR-204 and miR-126 inhibit HBV replication via two distinct mechanisms [22]. Here, SMARCE1 is linked to hepatocellular carcinoma.